Participate in Research Studies

Emory-CDC HIV/AIDS Clinical Trials Unit
Current Enrolling Studies

A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults:

RESEARCH STUDY A5336: This study is on the CURE agenda. This study is testing the safety and tolerability of the use of ruxolitinib in people living with HIV. The study hopes to decrease latent reservoirs (a group of immune cells infected but not actively producing new virus) and chronic inflammation..  READ MORE

Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of
HIV-1 Persistence and on HIV-1-Specific Immune Responses:

RESEARCH STUDY A5354: This study will include people who have very recently been infected with HIV and will start them on anti-HIV (antiretroviral) drugs right away to see how this may change HIV’s impact on the body. The study hopes to  limit the virus from getting into hidden areas of the body (“reservoirs”) and change how the immune system helps to control the virus. READ MORE

Randomized Trial to Prevent Vascular Events in HIV: REPRIEVE:

RESEARCH STUDY A5332: Statistics show that people living with HIV are 50-100% more likely to develop heart disease than those who are negative. The main purpose of this clinical trial is to see if pitavastatin can prevent heart disease and heart disease related deaths in people with HIV infection who are taking HIV medications. 


ACTG Contacts:
Anna Benbrook E: anna.r.benbrook@emory.edu P: 470.585.3655
Micheal Barber E:mtbarbe@emory.edu P: 404.576.0992


General Information: (404) 870-7700
STI Testing: (404) 870-7722
Volunteer: (404) 870-7764
Comment Line: (678) 999-1212